State of Wyoming’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

State of Wyoming’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,774	Closed	-$36K	–	2019
2021 Q3	$36K	Sell	1,774 -217	-11%	-$5.99K	0.02%	848
2021 Q2	$74K	Buy	1,991 +1,987	+49,675%	+$60.9K	0.05%	590
2021 Q1	$0	Buy	+4	New	+$102	﹤0.01%	565

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

State of Wyoming's DRNA Position: Q4 2021 in Review

State of Wyoming sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 1,774 shares — an estimated $36K sold.

State of Wyoming first reported a position in DRNA in Q1 2021 and held it in 3 quarters. The position peaked at $74K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

State of Wyoming reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
State of Wyoming sold 1,774 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $36K.
State of Wyoming first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2021 and held it in 3 quarters.
State of Wyoming's Dicerna Pharmaceuticals, Inc. position peaked at $74K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on State of Wyoming's 13F filing for Q4 2021, filed 11 Feb 2022.